EMCURE Quarterly Results, Profit & Loss, Balance Sheet (EMCURE)

EMCURE quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • EMCURE Financials
  • EMCURE Shareholding Pattern
  • EMCURE Earnings Documents
  • EMCURE Announcements
  • EMCURE Corporate Actions
  • EMCURE Bulk, Block & Insider Deals
  • EMCURE Delivery Data
  • EMCURE Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Emcure Pharmaceuticals Ltd (EMCURE) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Emcure Pharmaceuticals Ltd reported sales of ₹2,820 Cr, operating profit of ₹588 Cr (OPM 21%) and net profit of ₹325 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

EMCURE quarterly results (₹ Cr)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales1,9632,1162,1012,2702,3632,4702,5802,820
YoY Sales growth1819161320172324
Expenses1,6081,7141,6841,7941,8711,9902,0482,233
Operating Profit355402417475493480532588
OPM18%19%20%21%21%19%21%21%
Other Income4-603-361423
Interest3239273338463236
Depreciation979799105105106110110
Profit before tax230261291341314341394446
Tax32%24%26%26%26%29%26%27%
Net Profit156197215251231244292325
EPS in Rs8.119.9710.9212.8412.1612.8415.517.16
EMCURE profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales5,8555,9866,6587,8969,20410,234
Sales growth16211191721
Expenses4,5254,8045,4296,4277,4588,141
Operating Profit1,3301,1821,2301,4691,7462,093
OPM23%20%18%19%19%20%
Other Income63394762100-17
Interest176214237176144152
Depreciation245260312384415430
Profit before tax9737477279711,2871,494
Tax28%25%27%27%27%-
Net Profit7035625287079411,093
EPS in Rs36.6229.4227.535.9648.7657.66
Dividend Payout8%7%7%8%7%-
EMCURE balance sheet (₹ Cr)
MetricMar 2024Mar 2025Sep 2025Mar 2026Sep 2026
Equity Capital181189-190190
Reserves2,7714,257-4,7605,154
Borrowings2,3351,023-1,5211,791
Other Liabilities2,4222,653-3,0433,029
Total Liabilities7,7098,122-9,51410,164
Fixed Assets3,1253,197-3,3193,372
CWIP159177-273328
Investments31895-2020
Other Assets4,1084,652-5,9036,444
Total Assets7,7098,122-9,51410,164
EMCURE cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity7687471,097852944
Cash from Investing Activity-574-468-715-96-1,175
Cash from Financing Activity-152-145-164-814343
Net Cash Flow42134219-58112
Free Cash Flow349345801475400
CFO/OP81%80%107%75%70%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit81801077575
EMCURE ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days8210110293102
Inventory Days237223225224239
Days Payable184175193172180
Cash Conversion Cycle135148134145161
Working Capital Days922287662
ROCE26%21%19%20%24%
  • EMCURE Shareholding Pattern
  • EMCURE Earnings Concalls
  • EMCURE Growth Catalysts
  • EMCURE Corporate Actions
  • EMCURE Announcements
  • EMCURE Results & Documents
  • EMCURE Bulk & Block Deals
  • EMCURE Delivery Data